142 related articles for article (PubMed ID: 2320412)
1. Post-transcriptional control of c-myc proto-oncogene expression by glucocorticoid hormones in human T lymphoblastic leukemic cells.
Maroder M; Martinotti S; Vacca A; Screpanti I; Petrangeli E; Frati L; Gulino A
Nucleic Acids Res; 1990 Mar; 18(5):1153-7. PubMed ID: 2320412
[TBL] [Abstract][Full Text] [Related]
2. Glucocorticoid effect on oncogene/growth gene expression in human T lymphoblastic leukemic cell line CCRF-CEM. Specific c-myc mRNA suppression by dexamethasone.
Yuh YS; Thompson EB
J Biol Chem; 1989 Jun; 264(18):10904-10. PubMed ID: 2659598
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of c-erbA proto-oncogene expression by glucocorticoid hormones in S49.1 lymphoma cells.
Maroder M; Vacca A; Screpanti I; Petrangeli E; Frati L; Gulino A
Biochim Biophys Acta; 1989 Nov; 1009(2):188-90. PubMed ID: 2553102
[TBL] [Abstract][Full Text] [Related]
4. Glucocorticoid mediated transcriptional repression of c-myc in apoptotic human leukemic CEM cells.
Zhou F; Medh RD; Thompson EB
J Steroid Biochem Mol Biol; 2000; 73(5):195-202. PubMed ID: 11070348
[TBL] [Abstract][Full Text] [Related]
5. Glucocorticoid regulation of c-myc promoter utilization in P1798 T-lymphoma cells.
Ma T; Mahajan PB; Thompson EA
Mol Endocrinol; 1992 Jun; 6(6):960-8. PubMed ID: 1495494
[TBL] [Abstract][Full Text] [Related]
6. Changes in c-myc expression and the kinetics of dexamethasone-induced programmed cell death (apoptosis) in human lymphoid leukaemia cells.
Wood AC; Waters CM; Garner A; Hickman JA
Br J Cancer; 1994 Apr; 69(4):663-9. PubMed ID: 8142255
[TBL] [Abstract][Full Text] [Related]
7. Phorbol ester-mediated inhibition of growth and regulation of proto-oncogene expression in the human T cell leukemia line JURKAT.
Makover D; Cuddy M; Yum S; Bradley K; Alpers J; Sukhatme V; Reed JC
Oncogene; 1991 Mar; 6(3):455-60. PubMed ID: 2011401
[TBL] [Abstract][Full Text] [Related]
8. Suppression of c-myc is a critical step in glucocorticoid-induced human leukemic cell lysis.
Thulasi R; Harbour DV; Thompson EB
J Biol Chem; 1993 Aug; 268(24):18306-12. PubMed ID: 8394364
[TBL] [Abstract][Full Text] [Related]
9. The delayed induction of c-jun in apoptotic human leukemic lymphoblasts is primarily transcriptional.
Zhou F; Medh RD; Zhang W; Ansari NH; Thompson EB
J Steroid Biochem Mol Biol; 2000 Dec; 75(2-3):91-9. PubMed ID: 11226825
[TBL] [Abstract][Full Text] [Related]
10. Differential regulation and expression of jun, c-fos and c-myc proto-oncogenes during mouse liver regeneration and after inhibition of protein synthesis.
Morello D; Lavenu A; Babinet C
Oncogene; 1990 Oct; 5(10):1511-9. PubMed ID: 2123531
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional down-regulation of c-myc expression by protein synthesis-dependent and -independent pathways in a human T lymphoblastic tumor cell line.
Bading H; Moelling K
Cell Growth Differ; 1990 Mar; 1(3):113-7. PubMed ID: 2127692
[TBL] [Abstract][Full Text] [Related]
12. [Changes in the transcription activity of c-myc genes and heat shock proteins (HSP 70) after incubation of mouse plasmacytoma cells with dexamethasone].
Zatsepina OG; Evgen'ev MB; Liashchko VN
Mol Biol (Mosk); 1990; 24(2):391-5. PubMed ID: 2362589
[TBL] [Abstract][Full Text] [Related]
13. Glucocorticoid regulation of transcription of the c-myc cellular protooncogene in P1798 cells.
Forsthoefel AM; Thompson EA
Mol Endocrinol; 1987 Dec; 1(12):899-907. PubMed ID: 3153468
[TBL] [Abstract][Full Text] [Related]
14. Kinetics of cellular oncogene expression in mouse lymphocytes. II. Regulation of c-fos and c-myc gene expression.
Schneider-Schaulies J; Schimpl A; Wecker E
Eur J Immunol; 1987 May; 17(5):713-8. PubMed ID: 3556196
[TBL] [Abstract][Full Text] [Related]
15. Regulation of tyrosine hydroxylase gene transcription rate and tyrosine hydroxylase mRNA stability by cyclic AMP and glucocorticoid.
Fossom LH; Sterling CR; Tank AW
Mol Pharmacol; 1992 Nov; 42(5):898-908. PubMed ID: 1359399
[TBL] [Abstract][Full Text] [Related]
16. Uncoupling of growth inhibition and differentiation in dexamethasone-treated human rhabdomyosarcoma cells.
De Giovanni C; Lollini PL; Dolcetti R; Landuzzi L; Nicoletti G; D'Andrea E; Scotland K; Nanni P
Br J Cancer; 1993 Apr; 67(4):674-9. PubMed ID: 8471424
[TBL] [Abstract][Full Text] [Related]
17. c-myc and c-fos gene regulation during mouse liver regeneration.
Sobczak J; Mechti N; Tournier MF; Blanchard JM; Duguet M
Oncogene; 1989 Dec; 4(12):1503-8. PubMed ID: 2512526
[TBL] [Abstract][Full Text] [Related]
18. Tissue-specific post-transcriptional regulation of c-myc expression in normal and H-2K/human c-myc transgenic mice.
Morello D; Asselin C; Lavenu A; Marcu KB; Babinet C
Oncogene; 1989 Aug; 4(8):955-61. PubMed ID: 2668846
[TBL] [Abstract][Full Text] [Related]
19. Elongation and maturation of c-myc RNA is inhibited by differentiation inducing agents in HL60 cells.
Eick D
Nucleic Acids Res; 1990 Mar; 18(5):1199-205. PubMed ID: 2320415
[TBL] [Abstract][Full Text] [Related]
20. Modulation of a constitutive transcriptional block at exon-1 controls human c-myc oncogene expression.
Re GG; Antoun GR; Zipf TF
Oncogene; 1990 Aug; 5(8):1247-50. PubMed ID: 1697411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
